Evidence map›Paper›PMID 32712929›Full record

SynthesisInternational journal of colorectal disease2020

Management options for chronic anal fissure: a systematic review of randomised controlled trials.

P A Boland, M E Kelly, N E Donlon, J C Bolger, J O Larkin, B J Mehigan, P H McCormick

Abstract readSystematic Review
PubMed Publisher
In one paragraph

Synthesis in International journal of colorectal disease, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 2 pooled it
8.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 2 syntheses or guidelines pooled it, 74 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Anal Fissure and Its Treatments: A Historical Review.Journal of clinical medicine · 2024
    Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

P A BolandDepartment of Colorectal Surgery, St James' Hospital, Dublin, 8, Ireland. patrick.boland.1@ucdconnect.ie.ORCID https://orcid.org/0000-0002-5844-7695
M E KellyDepartment of Colorectal Surgery, St James' Hospital, Dublin, 8, Ireland.
N E DonlonDepartment of Colorectal Surgery, St James' Hospital, Dublin, 8, Ireland.
J C BolgerDepartment of Colorectal Surgery, St James' Hospital, Dublin, 8, Ireland.
J O LarkinDepartment of Colorectal Surgery, St James' Hospital, Dublin, 8, Ireland.
B J MehiganDepartment of Colorectal Surgery, St James' Hospital, Dublin, 8, Ireland.
P H McCormickDepartment of Colorectal Surgery, St James' Hospital, Dublin, 8, Ireland.
St. James's Hospital · IESt. Patrick's Hospital · IE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionAnal fissure is the most common cause of severe anorectal pain in adults, contributing significantly to coloproctology workloads. There are a wide variety of management options available, including topical nitrites, calcium channel blockers, botulinum toxin injection and sphincterotomy. The aim of this study was to review current options for the treatment of chronic anal fissure.

methodsA comprehensive search identifying randomized controlled trials comparing treatment options for anal fissure published between January 2000 and February 2020 was performed. The primary outcome assessed was healing at 8 weeks post commencing treatment. Secondary outcomes included recurrence, intolerance of treatment and complications.

resultsA total of 2822 studies were identified. After removal of duplicates and non-relevant studies, we identified nine randomized controlled trials which met pre-defined criteria. There was a total of 775 patients. At 8 weeks, healing rates were 95.13% in those treated with sphincterotomy, 66.7% in the botulinum toxin group, 63.8% in the nitrate group, 52.3% for topical diltiazem and 50% for topical minoxidil. Recurrence was highest amongst those treated with botulinum toxin injection (41.7%) and lowest for sphincterotomy (6.9%). Although the absolute number is low, there was a risk of permanent incontinence with sphincterotomy.

conclusionThis review of the randomized control data demonstrates that healing was significantly higher amongst those treated with sphincterotomy versus more conservative modalities. Topical nitrites had similar outcomes to botulinum toxin injection but were poorly tolerated in comparison to other treatments. The benefit of sphincterotomy was at a cost of increased complications, notably permanent incontinence.

Indexed as

Botulinum Toxins, Type AFissure in AnoAdultAnal CanalChronic DiseaseHumansNeoplasm Recurrence, LocalRandomized Controlled Trials as TopicTreatment OutcomeBotulinum Toxins, Type AAnal fissureBenign colorectal diseaseFissure-in-ano

Identifiers

PMID32712929
OpenAlexW3045278106

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.